Toward Total Implantability Using Free-Range Resonant Electrical Energy Delivery System: Achieving Untethered Ventricular Assist Device Operation Over Large Distances

Cardiology Clinics

Volumn 29, Issue 4, 2011, Pages 609-625

  Waters, Benjamin ^a   Sample, Alanson ^a   Smith, Joshua ^a   Bonde, Pramod ^b  

^a University of Washington   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Free Range Resonant Electrical Energy Delivery system; Heart disease; Heart failure; Mechanical support; Ventricular assist device; Wireless power

Indexed keywords

ARTIFICIAL HEART; BIVENTRICULAR ASSIST DEVICE; CONSERVATIVE TREATMENT; ELECTRIC CAPACITANCE; ELECTROMAGNETIC FIELD; HEART ASSIST DEVICE; HEART FAILURE; HEART VALVE PROSTHESIS; HOSPITAL READMISSION; HUMAN; IMPLANT; INCIDENCE; MAGNETIC FIELD; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW;

AMBULATORY CARE; ELECTRIC POWER SUPPLIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PATIENT READMISSION; PATIENT SAFETY; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; WIRELESS TECHNOLOGY;

EID: 80655128350     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2011.08.002     Document Type: Review

References (29)

1. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: first annual report-2003. J Heart Lung Transplant 2003, 22(6):653-662.
2. Holman W.L., Kormos R.L., Naftel D.C., et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant 2009, 28(1):44-50.
3. Miller L.W., Pagani F.D., Russell S.D., et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357(9):885-896.
4. Pagani F.D., Miller L.W., Russell S.D., et al. HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009, 54(4):312-321.
5. Slaughter M.S., Rogers J.G., Milano C.A., et al. HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361(23):2241-2251.
6. Genovese E.A., Dew M.A., Teuteberg J.J., et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009, 88(4):1162-1170.
7. Martin S.I., Wellington L., Stevenson K.B., et al. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg 2010, 11(1):20-23.
8. Holman W.L., Pamboukian S.V., McGiffin D.C., et al. Device related infections: are we making progress?. J Card Surg 2010, 25(4):478-483.
9. Raymond A.L., Kfoury A.G., Bishop C.J., et al. Obesity and left ventricular assist device driveline exit site infection. ASAIO J 2010, 56(1):57-60.
10. Zierer A., Melby S.J., Voeller R.K., et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 2007, 84(2):515-520.
11. Allen J.G., Weiss E.S., Schaffer J.M., et al. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant 2010, 29(3):278-285.
12. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis. J Am Dent Assoc 2008, 139(Suppl):3S-24S.
13. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 2003, 108(16):2015-2031.
14. Kurtz S.M., Lau E., Schmier J., et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008, 23(7):984-991.
15. Holman W.L., Park S.J., Long J.W., et al. REMATCH Investigators. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 2004, 23(12):1359-1365.
16. Gordon R.J., Quagliarello B., Lowy F.D. Ventricular assist device-related infections. Lancet Infect Dis 2006, 6(7):426-437.
17. Monkowski D.H., Axelrod P., Fekete T., et al. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis 2007, 9(2):114-120.
18. Baddour L.M., Epstein A.E., Erickson C.C., et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010, 121(3):458-477.
19. Schaffer J.M., Allen J.G., Weiss E.S., et al. Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. J Heart Lung Transplant 2011, 30(2):164-174.
20. Topkara V.K., Kondareddy S., Malik F., et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg 2010, 90(4):1270-1277.
21. Siegenthaler M.P., Martin J., Pernice K., et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 2003, 23(5):748-754. [discussion: 754-5].
22. Holman W.L., Kirklin J.K., Naftel D.C., et al. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg 2010, 139(6). 1632, e2-6.
23. Dew M.A., Kormos R.L., Winowich S., et al. Human factors issues in ventricular assist device recipients and their family caregivers. ASAIO J 2000, 46(3):367-373.
24. Kormos R.L., Teuteberg J.J., Pagani F.D., et al. HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010, 139(5):1316-1324.
25. Hravnak M., George E., Kormos R.L. Management of chronic left ventricular assist device percutaneous lead insertion sites. J Heart Lung Transplant 1993, 12(5):856-863.
26. Haj-Yahia S., Birks E.J., Rogers P., et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg 2007, 134(1):199-203.
27. El-Banayosy A., Arusoglu L., Kizner L., et al. Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 2003, 75(5):1469-1475.
28. Bonde P, Bermudez C, Lockard KL, et al. The Ventricular Assist Device (VAD) Driveline: What is The Price of Living with This Technology? International Society of Heart Lung Transplantation. 30th Annual Meeting and Scientific Sessions. Chicago, 2010.
29. Bonde P, Dew MA, Meyer D, et al. National Trends in Readmission (REA) Rates Following Left Ventricular Assist Device (LVAD) Therapy, International Society of Heart Lung Transplantation. 31st Annual Meeting. San Diego, April 15, 2011.